In Vitro Activities of Garenoxacin (BMS 284756) against 108 Clinical Isolates of Gardnerella vaginalis

Garenoxacin (BMS 284756) was active against 105 of 108 (97%) recent clinical Gardnerella vaginalis isolates at ≤2 μg/ml by using the reference agar dilution method for anaerobes. Twenty-eight percent of isolates (31 of 108) were resistant to metronidazole, and 44% were resistant to doxycycline. All...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Goldstein, Ellie J. C., Citron, Diane M., Merriam, C. Vreni, Warren, Yumi A., Tyrrell, Kerin L., Fernandez, Helen T.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2002
Aiheet:	Susceptibility
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC132768/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12435709/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.12.3995-3996.2002
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!